Home » Topics » Regulatory » Patents

Patents
RSS

Shenzhen Targetrx Biotechnology patents EGFR double-mutant inhibitors

Jan. 23, 2019

New PRMT5 inhibitors presented by Bayer

Jan. 23, 2019

Beijing Foreland Pharma identifies lysophospholipid S1P1 receptor ligands

Jan. 23, 2019

AstraZeneca divulges new SERDs

Jan. 23, 2019

Esteve Pharmaceuticals presents new analgesics

Jan. 23, 2019

Selvita presents adenosine A2A receptor antagonists

Jan. 21, 2019

Xiamen University divulges RET inhibitors

Jan. 21, 2019

Birdie Biopharmaceuticals discovers resiquimod salts

Jan. 18, 2019

Gruenenthal presents new phosphodiesterase PDE4B inhibitors

Jan. 18, 2019

Daiichi Sankyo patents histone acetyltransferase p300/CREB-binding protein inhibitors

Jan. 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...